PLoS ONE · 2018 · 14 citations · 31 references
Life SciencesInfectious DiseasesMicrobiologyBacteriologyDiagnostic MicrobiologyMedical MicrobiologyBacterial EpidemiologyBacterial GeneticsBacterial IdentificationClinical BacteriologyDiagnostic BacteriologyPlasmid-mediated ResistanceAmpc Beta-lactamase-mediated ResistanceAmpc Beta-lactamasesBeta-lactamase GenesDisease Prevalence SurveysEnrichment BrothEscherichia ColiHospital-based PrevalencePlasmid-mediated Beta-lactam Resistance
OBJECTIVE: The objective of this study is to determine the prevalence of rectal carriage of plasmid- and chromosome-encoded AmpC β-lactamase-producing Escherichia coli and Klebsiella spp. in patients in a Dutch teaching hospital between 2013 and 2016. METHODS: Between 2013 and 2016, hospital-wide yearly prevalence surveys were performed to determine the prevalence of AmpC β-lactamase-producing E. coli and Klebsiella spp. rectal carriage. Rectal swabs were taken and cultured using an enrichment broth and selective agar plates. All E. coli and Klebsiella spp. isolates were screened for production of AmpC β-lactamase using phenotypic confirmation tests and for the presence of plasmid-encoded AmpC (pAmpC) genes. E. coli isolates were screened for chromosome-encoded AmpC (cAmpC) promoter/attenuator alterations. RESULTS: Fifty (2.4%) of 2,126 evaluable patients were identified as rectal carrier of AmpC β-lactamase-producing E. coli. No carriage of AmpC β-lactamase producing Klebsiella spp. was found. Nineteen (0.9%) patients harboured isolates with pAmpC genes and 30 (1,4%) patients harboured isolates with cAmpC promoter/attenuator alterations associated with AmpC β-lactamase overproduction. For one isolate, no pAmpC genes or cAmpC promotor/attenuator alterations could be identified. During the study period, a statistically significant decline in the prevalence of rectal carriage with E. coli with cAmpC promotor/attenuator alterations was found (p = 0.012). The prevalence of pAmpC remained stable over the years. CONCLUSIONS: The prevalence of rectal carriage of AmpC-producing E. coli and Klebsiella spp. in patients in Dutch hospitals is low and a declining trend was observed for E. coli with cAmpC promotor/attenuator alterations.
31
Daniel D. Murray, Kazuo Suzuki, Matthew Law et al. · PLoS ONE · 2015 · 2.7K citations · Full text
Jan Kluytmans, I. T. M. A. Overdevest, Ina Willemsen et al. · Clinical Infectious Diseases · 2012 · 251 citations
C.M. Dierikx, Engeline van Duijkeren, A. Schoormans et al. · Journal of Antimicrobial Chemotherapy · 2012 · 224 citations · Full text